Delcath Systems (DCTH)
(Real Time Quote from BATS)
$7.65 USD
+0.02 (0.26%)
Updated Jun 17, 2024 09:51 AM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Price, Consensus and EPS Surprise
DCTH 7.65 +0.02(0.26%)
Will DCTH be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for DCTH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DCTH
Here's What Could Help Delcath Systems (DCTH) Maintain Its Recent Price Strength
Beat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus
DCTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does Delcath Systems (DCTH) Have the Potential to Rally 197.87% as Wall Street Analysts Expect?
Wall Street Analysts Predict a 201.72% Upside in Delcath Systems (DCTH): Here's What You Should Know
What Makes Delcath Systems (DCTH) a Good Fit for 'Trend Investing'
Other News for DCTH
Have $5-10? 7 Affordable Stocks That Are About to Breakout.
Delcath Systems’ Governance Changes and Shareholder Decisions
Wall Street Analysts Are Bullish on Top Healthcare Picks
Delcath Systems: Strong Financials and HEPZATO KIT Growth Prompt Buy Rating and Raised Price Target
Delcath Systems price target raised by $2 at H.C. Wainwright, here's why